Shilpa Medicare to foray into R&D activities of specific drug processes

28 May 2019 Evaluate

Shilpa Medicare has received approval to foray into the R&D activities of specific drug processes by roping prominent technocrats through a new subsidiary company incorporated as Sravathi Advance Process Technologies. The Board of Directors of the Company at its meeting held on May 27, 2019 has approved the same.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

320.50 0.15 (0.05%)
30-Dec-2025 10:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.15
Dr. Reddys Lab 1270.80
Cipla 1487.60
Zydus Lifesciences 901.20
Lupin 2081.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×